Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hepatic Encephalopathy-Associated Cerebral Vasculopathy in Acute-on-Chronic Liver Failure: Alterations on Endothelial Factor Release and Influence on Cerebrovascular Function.
Caracuel L, Sastre E, Callejo M, Rodrigues-Díez R, García-Redondo AB, Prieto I, Nieto C, Salaices M, Aller MÁ, Arias J, Blanco-Rivero J. Caracuel L, et al. Among authors: callejo m. Front Physiol. 2020 Nov 20;11:593371. doi: 10.3389/fphys.2020.593371. eCollection 2020. Front Physiol. 2020. PMID: 33329042 Free PMC article.
Activation of PPARβ/δ prevents hyperglycaemia-induced impairment of Kv7 channels and cAMP-mediated relaxation in rat coronary arteries.
Morales-Cano D, Moreno L, Barreira B, Briones AM, Pandolfi R, Moral-Sanz J, Callejo M, Mondejar-Parreño G, Cortijo J, Salaices M, Duarte J, Perez-Vizcaino F, Cogolludo A. Morales-Cano D, et al. Among authors: callejo m. Clin Sci (Lond). 2016 Oct 1;130(20):1823-36. doi: 10.1042/CS20160141. Epub 2016 Jul 13. Clin Sci (Lond). 2016. PMID: 27413020
miR-1 induces endothelial dysfunction in rat pulmonary arteries.
Mondejar-Parreño G, Callejo M, Barreira B, Morales-Cano D, Esquivel-Ruiz S, Filice M, Moreno L, Cogolludo A, Perez-Vizcaino F. Mondejar-Parreño G, et al. Among authors: callejo m. J Physiol Biochem. 2019 Nov;75(4):519-529. doi: 10.1007/s13105-019-00696-2. Epub 2019 Aug 20. J Physiol Biochem. 2019. PMID: 31432395
Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model.
Morales-Cano D, Izquierdo-García JL, Barreira B, Esquivel-Ruiz S, Callejo M, Pandolfi R, Villa-Valverde P, Rodríguez I, Cogolludo A, Ruiz-Cabello J, Perez-Vizcaino F, Moreno L. Morales-Cano D, et al. Among authors: callejo m. Front Pharmacol. 2023 Mar 29;14:1021535. doi: 10.3389/fphar.2023.1021535. eCollection 2023. Front Pharmacol. 2023. PMID: 37063275 Free PMC article.
Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model.
Morales-Cano D, Izquierdo-García JL, Barreira B, Esquivel-Ruiz S, Callejo M, Pandolfi R, Villa-Valverde P, Rodríguez I, Cogolludo A, Ruiz-Cabello J, Perez-Vizcaino F, Moreno L. Morales-Cano D, et al. Among authors: callejo m. Front Pharmacol. 2023 Jun 12;14:1228923. doi: 10.3389/fphar.2023.1228923. eCollection 2023. Front Pharmacol. 2023. PMID: 37377931 Free PMC article.
60 results